Definition
An adverse drug reaction describes a harmful or unintended response that is suspected to be related to exposure to a medicinal product. The term is used in both clinical and regulatory settings to distinguish product-related harm from unrelated events or background illness.
These reactions may be expected, known, or unexpected depending on the product profile and the available evidence. Each case contributes to safety evaluation, ongoing monitoring, and assessment of the product’s evolving benefit-risk balance.
Why It Matters
Adverse drug reactions are a core part of pharmacovigilance because they provide the evidence needed to detect new risks, assess seriousness, and decide whether further action is required. Even a single well-documented event can influence internal review or regulatory communication if it points to a meaningful pattern.
For sponsors and market authorization holders, the ability to capture, review, and interpret these reports effectively is essential for maintaining trust and meeting reporting expectations. This links naturally with ICSR handling and signal detection.
How It Relates to MedNova
MedNova supports organizations that need strong systems for identifying, documenting, and evaluating adverse events in a way that is both operationally practical and compliant. Our work helps teams connect safety data with decision-making, reporting readiness, and sustained oversight.
That support can span case intake, medical review, signal monitoring, and broader pharmacovigilance process design.